1. Home
  2. RGNX vs GRRR Comparison

RGNX vs GRRR Comparison

Compare RGNX & GRRR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • RGNX
  • GRRR
  • Stock Information
  • Founded
  • RGNX 2008
  • GRRR 2001
  • Country
  • RGNX United States
  • GRRR United Kingdom
  • Employees
  • RGNX N/A
  • GRRR N/A
  • Industry
  • RGNX Biotechnology: Biological Products (No Diagnostic Substances)
  • GRRR Computer Software: Prepackaged Software
  • Sector
  • RGNX Health Care
  • GRRR Technology
  • Exchange
  • RGNX Nasdaq
  • GRRR Nasdaq
  • Market Cap
  • RGNX 424.8M
  • GRRR 417.6M
  • IPO Year
  • RGNX 2015
  • GRRR N/A
  • Fundamental
  • Price
  • RGNX $8.17
  • GRRR $16.30
  • Analyst Decision
  • RGNX Strong Buy
  • GRRR Buy
  • Analyst Count
  • RGNX 8
  • GRRR 1
  • Target Price
  • RGNX $31.75
  • GRRR $18.00
  • AVG Volume (30 Days)
  • RGNX 542.3K
  • GRRR 1.7M
  • Earning Date
  • RGNX 08-07-2025
  • GRRR 09-29-2025
  • Dividend Yield
  • RGNX N/A
  • GRRR N/A
  • EPS Growth
  • RGNX N/A
  • GRRR N/A
  • EPS
  • RGNX N/A
  • GRRR N/A
  • Revenue
  • RGNX $156,718,000.00
  • GRRR $84,196,961.00
  • Revenue This Year
  • RGNX $327.08
  • GRRR $38.13
  • Revenue Next Year
  • RGNX N/A
  • GRRR $28.55
  • P/E Ratio
  • RGNX N/A
  • GRRR N/A
  • Revenue Growth
  • RGNX 80.70
  • GRRR 19.91
  • 52 Week Low
  • RGNX $5.04
  • GRRR $2.12
  • 52 Week High
  • RGNX $13.48
  • GRRR $44.15
  • Technical
  • Relative Strength Index (RSI)
  • RGNX 45.17
  • GRRR 38.66
  • Support Level
  • RGNX $8.27
  • GRRR $15.49
  • Resistance Level
  • RGNX $9.32
  • GRRR $16.66
  • Average True Range (ATR)
  • RGNX 0.49
  • GRRR 0.84
  • MACD
  • RGNX -0.04
  • GRRR -0.20
  • Stochastic Oscillator
  • RGNX 20.16
  • GRRR 16.01

About RGNX REGENXBIO Inc.

Regenxbio Inc is a biotechnology company. Its main activity is the development and commercialization of recombinant adeno associated virus gene therapy to correct an underlying genetic defect. The diseases that the Regenxbio platform targets are metabolic (homozygous familial hypercholesterolemia), neurodegenerative conditions (mucopolysaccharidosis), and retinal diseases (wet age-related macular degeneration, X-linked retinitis pigmentosa). The company derives the majority of its revenue from the United States.

About GRRR Gorilla Technology Group Inc.

Gorilla Technology Group Inc is engaged in providing information, software, and data processing services. It is a provider of video intelligence, Internet of Things (IoT) security, edge AI data analytics, and operational technology (OT) security solutions and services. Its reportable segments are video IoT and security convergence and Other segments.

Share on Social Networks: